Greenwich LifeSciences, Inc.
NASDAQ:GLSIBiotechnology
-$0.74 today
- Market cap
- $302.08M
- Beta
- 1.38
- P/E (TTM)
- -15.6
- EPS (TTM)
- -$1.49
Volume 0.71M
Average 0.14M
GLSI Other Current Assets
Current assets not reported separately, such as prepaid expenses.
Greenwich LifeSciences, Inc.NASDAQ: GLSI
Other Current Assets · Q1 FY2026 · quarter ended Mar 2026
Other current assets remains negative
Q1 FY2026 other current assets was $0, compared with $0 a year earlier.
Context
- Other current assets amounted to 0.0% of total assets at the end of Q1 FY2026, unchanged from a year earlier.
- Other current assets increased in 0 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
Sources:Balance SheetText generated from reported figures; not investment advice.
Other Current Assets history
USD · from the balance sheet
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Other Current Assets | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
| FY2021 | 2021-12-31 | 0 | — |
Other Current Assets vs competitors
How GLSI compares with its peers on the latest reported figures
- Peers report in different currencies, so other current assets is compared through growth and share of total assets rather than absolute size.
- Other current assets amounts to 0.0% of total assets for GLSI, versus a peer median of 1.2%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
IRDOpus Genetics, Inc. | Mar 2026 | $3.93M USD | +184.6% | +181.7% | 5.9% |
| Mar 2026 | $2.59M USD | -17.1% | -3.4% | 1.0% | |
| Mar 2026 | $2.04M USD | +17.6% | +40.7% | 1.7% | |
| Mar 2026 | $2.04M USD | -15.9% | — | 1.1% | |
| Mar 2026 | $1.03M USD | — | — | 2.8% | |
| Mar 2026 | $367.51K USD | -47.7% | +36.9% | 1.2% | |
| Mar 2026 | $335.74K USD | +99.4% | +24.5% | 0.4% | |
| Mar 2026 | $0 USD | — | — | 0.0% | |
| Mar 2026 | CA$0 CAD | -100.0% | — | 0.0% | |
| Peer median (excluding GLSI) | — | -15.9% | +36.9% | 1.2% | |
Competitors are the stored peer set for GLSI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Greenwich LifeSciences, Inc.
NASDAQ:GLSI
Intrinsic Alpha fair value
Locked
Current Price
$20.58
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.